On this page of Benford's Law Stocks.com we present our study of Actinium Pharmaceuticals, Inc. — ticker symbol ATNM. SEC filings have been screened by our Benford's Law software, for quarterly 10Q and annual 10K filings from 3/29/2024 to 5/9/2025 for Actinium Pharmaceuticals, Inc. under CIK number 0001388320. For filings made in XBRL (eXtensible Business Reporting Language) format, our algorithm extracts all "tagged" numbers presented by the company; for any non-XBRL filings our algorithm uses its own interal set of rules to extract what it believes to be numbers as found throughout the filings. The format found for each filing is presented below together with the results for ATNM, with the percentage of found numbers beginning with each digit (1's, 2's, 3's, 4's, 5's, 6's, 7's, 8's, and 9's) charted against the "normal" range observed throughout our coverage universe, as well as the "normal" range for Actinium Pharmaceuticals, Inc. based on the past ATNM filings our system processed in the past.
26.0
12.8
18.7
7.3
4.6
6.8
12.8
6.8
4.1
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
XBRL?   [ original filing, ATNM stockholder letter ]
Total numbers found: 219
Recent share count: 31,195,891 (3's column)

= Typical range across full coverage universe
Benford's Law Stocks Indicator
219
Low count compared to other filers, falling in the bottom quartile. At this number count, it would take about 2 numbers to move any given column by a full percentage point.
33

Starting from a possible score of 100, we made the following score deductions:
 • We deducted point upon observing the 2's percentage was below the typical coverage universe range.
 • We deducted point upon observing the 2's percentage was below the company's typical historical range.
 • The 3's percentage was higher than the 2's percentage, increasing the penalty multiplier.
 • However, because we observed that the company's shares outstanding count begins with the digit 3, we canceled the penalty multiplier.
 • We deducted points upon observing the 3's percentage was above the typical coverage universe range.
 • We deducted points upon observing the 5's percentage was below the typical coverage universe range.
 • We deducted points upon observing the 5's percentage was below the company's typical historical range.
 • The 6's percentage was higher than the 5's percentage, increasing the penalty multiplier.
 • The 7's percentage was higher than the 6's percentage, increasing the penalty multiplier.
 • This is the 2nd column with percentage higher than the prior column, resulting in a penalty deduction.
 • We deducted points (includes the impact of penalty multiplier) upon observing the 7's percentage was above the typical coverage universe range.
 • We deducted points (includes the impact of penalty multiplier) upon observing the 7's percentage was above the company's typical historical range.
 • We deducted points upon observing the 8's percentage was above the typical coverage universe range.
Benford's Law Stocks Indicator
ATNM
Low score compared to other filers, falling in the bottom quartile.
BGFV
INVE
ANSCU
TRAK
EMKR
RCAT
PMVC
KWIK
Check our work! We provide our Actinium Pharmaceuticals, Inc. Benford's Law analysis for informational purposes only, and our software should be expected to make mistakes and contain errors (nothing you see on this website should be relied upon for any decision-making without first repeating the analysis yourself independently), and so below we present to you all of the numbers our system detected, for the ATNM filing above. This way, you can open the filing on your own and compare what you see below against what you yourself find. This can also be helpful for exploring any columns in particular that caught your eye.

1's 2's 3's
We found 57 numbers that start with the digit 1. Here they are:
1,131
1,602
1,530
1,685
17
11
11
1,000,000,000
16,638
16,638
15,938
15,938
15,938
1,378
1,378
1,752,050
1
14,694
14,695
10,148
15,938
1,378
1,047
138
129
11
11
14,695
14,768
1,439
1
173
173
1
1
156
153
11
1,498
19
1
1,415
18
1.8
15.0
14.7
1.43
152
1.06
1.43
1.2
1.8
1
1
17.33
17.33
17.77
We found 28 numbers that start with the digit 2. Here they are:
20
25,694
2,962
27,886,486
25,694
27,634,213
28
29,396,411
29
205
216
271
2
2
2
271
2
2
2
2
2
200
200
25
271
25
28
2
We found 41 numbers that start with the digit 3. Here they are:
31,195,891
317
364
327
324
35,000
35,000
31,195,891
31,195,891
31
31
391,764
375,826
32,758
31
31,195,891
31,195,891
31
375,826
32,758
31,195,891
31
391,764
373,934
337,583
36,379
390,081
346,253
327
324
300
305
3
3
3
3
380
35
35
300
300
4's 5's 6's
We found 16 numbers that start with the digit 4. Here they are:
42,953
44,141
417,427
408,553
408,553
417,427
43,857
470
440
4.8
475
4,891
4.0
4.5
4.9
4
We found 10 numbers that start with the digit 5. Here they are:
579
569
50,000,000
51
5,421
578
500
5,137
5.85
5.85
We found 15 numbers that start with the digit 6. Here they are:
65,325
66,456
68,647
6,520
68,647
6,635
65,652
65,325
65,652
6
6.2
643
6.48
6.45
6.49
7's 8's 9's
We found 28 numbers that start with the digit 7. Here they are:
72,904
74,506
76,899
7,568
7,110
7
76,899
7,700
700
700
75
75
7,574
7,374
75
7,576
7,383
73,228
76,990
72,904
73,228
7
7,165
75
7.54
7
7
7
We found 15 numbers that start with the digit 8. Here they are:
891
8,148
836
8,938
8,670
8,874
8,874
8,670
8,670
8,670
8,874
84,373
8
83
8.7
We found 9 numbers that start with the digit 9. Here they are:
939
984
9
9,597
9,597
927
927
90.6
90.7
While the above ATNM 10Q Filed 5/9/2025 is interesting in isolation, we have found that it is also useful to take a look at older Actinium Pharmaceuticals, Inc. filings processed by our Benford's Law Stocks algorithm, to see how the company's filings "typically look" on a Benford's Law analysis. Below we repeat the 10Q Filed 5/9/2025 but instead of the chart comparing against the typical company across our coverage universe, below we show the same chart compared against the typical ATNM 10Q and 10K filings that we have processed historically. This is followed by similar charts for each of those historical filings.

26.0
12.8
18.7
7.3
4.6
6.8
12.8
6.8
4.1
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 33
XBRL?   [ original filing ]
Total numbers found: 219

= Typical ATNM range from 3/29/2024 to 5/9/2025
30.1
18.9
17.6
5.1
8.8
5.1
4.7
5.1
4.7
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 86
XBRL?   [ original filing ]
Total numbers found: 296

= Typical ATNM range from 3/29/2024 to 5/9/2025
23.5
13.7
20.4
8.1
9.5
6.7
8.4
6.7
2.8
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 67
XBRL?   [ original filing ]
Total numbers found: 357

= Typical ATNM range from 3/29/2024 to 5/9/2025
31.9
15.5
16.0
4.6
7.1
3.8
9.2
8.0
3.8
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 53
XBRL?   [ original filing ]
Total numbers found: 238

= Typical ATNM range from 3/29/2024 to 5/9/2025
28.1
14.7
21.2
7.2
7.2
3.8
7.8
5.3
4.7
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 84
XBRL?   [ original filing ]
Total numbers found: 320

= Typical ATNM range from 3/29/2024 to 5/9/2025
24.7
19.0
19.2
8.8
7.4
8.8
5.5
4.7
1.9
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 61
XBRL?   [ original filing ]
Total numbers found: 364

= Typical ATNM range from 3/29/2024 to 5/9/2025
 

Benford's Law ATNM Stock (Actinium Pharmaceuticals, Inc.) | www.Benford'sLawStocks.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in BenfordsLawStocks.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.